AÏDA ONCOLOGY Aps: Financial statements 2023
CVR: 42246468
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AÏDA ONCOLOGY Aps (CVR 42246468) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,168,557 and a net result of DKK -2,360,146 compared with DKK -179,673 the year before. Equity in the 2023 report amounted to DKK -2,504,819. The company had 1 employee in the financial year.
- Gross Profit
- DKK -2,168,557
- Profit/Loss
- DKK -2,360,146
- Equity
- DKK -2,504,819
- Total Assets
- DKK 1,728,557
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -2.2 mio. | -2.4 mio. | -2.5 mio. | 1 |
| 2022 | 0 | -179 t. | -180 t. | -145 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 30, 2023, Ida Kappel Buhl is registered as an owner of AÏDA ONCOLOGY Aps with an ownership share of 5%.
AÏDA ONCOLOGY Aps has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -179,673.
About AÏDA ONCOLOGY Aps
AÏDA ONCOLOGY Aps is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ulla Hald Buhl and Claus Frisenberg Pedersen. The board consists of Neil Goldsmith (chair), Claus Frisenberg Pedersen, Peter Buhl and Ulla Hald Buhl. The company's owners include Ida Kappel Buhl, BUHL KRONE HOLDING ApS and Arrow Strategy Holding 2 ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -1,913,891 and a net result of DKK -5,579,964 compared with DKK -2,613,422 the year before. Equity in the 2025 report amounted to DKK -10,698,205.